U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H27N5O7S
Molecular Weight 493.533
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ASPOXICILLIN

SMILES

CNC(=O)C[C@@H](N)C(=O)N[C@@H](C(=O)N[C@H]1[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O)C3=CC=C(O)C=C3

InChI

InChIKey=BHELIUBJHYAEDK-OAIUPTLZSA-N
InChI=1S/C21H27N5O7S/c1-21(2)15(20(32)33)26-18(31)14(19(26)34-21)25-17(30)13(9-4-6-10(27)7-5-9)24-16(29)11(22)8-12(28)23-3/h4-7,11,13-15,19,27H,8,22H2,1-3H3,(H,23,28)(H,24,29)(H,25,30)(H,32,33)/t11-,13-,14-,15+,19-/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H27N5O7S
Molecular Weight 493.533
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Aspoxicillin is an injectable, amino acid-type penicillin highly active against Gram-positive ad Gram-negative bacteria, including the beta-lactamase producing Bacillus fragilis. It is reportedly effective in the treatment of peritonitis, pneumonia and bronchitis. Adverse reactions are: rash, urticaria, skin itching, vomiting, abdominal pain.

Originator

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Doyle
Curative
Doyle
Curative
Doyle

Cmax

ValueDoseCo-administeredAnalytePopulation
73.6 μg/g
2 g single, intravenous
ASPOXICILLIN unknown
Homo sapiens
40.3 μg/g
2 g single, intravenous
ASPOXICILLIN unknown
Homo sapiens

T1/2

ValueDoseCo-administeredAnalytePopulation
1.3 h
2 g single, intravenous
ASPOXICILLIN unknown
Homo sapiens
1.4 h
2 g single, intravenous
ASPOXICILLIN unknown
Homo sapiens

Doses

AEs

PubMed

Patents

Sample Use Guides

In Vivo Use Guide
1-2 g twice a day, in severe infections – 6-8 g per day
Route of Administration: Intravenous
In Vitro Use Guide
The MIC90 values of aspoxicillin was 0.05 ug/ml for Actinobacillus pleuropneumoniae.
Substance Class Chemical
Record UNII
0745KNO26J
Record Status Validated (UNII)
Record Version